TITLE

Comparison of isoproterenol and dobutamine in the induction of cardiac hypertrophy and fibrosis

AUTHOR(S)
Anderson, M.; Moore, D.; Larson, D. F.
PUB. DATE
July 2008
SOURCE
Perfusion;Jul2008, Vol. 23 Issue 4, p231
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Isoproterenol (Iso) was a clinical therapeutic that is now used as a research means for the induction of cardiac hypertrophy. Currently, dobutamine (Dob) has replaced Iso as the preferred inotropic β-adrenergic agent to wean patients from cardiopulmonary bypass and to sustain adequate cardiac function during the postoperative period. We sought to compare the cardiac structural and functional effects of long-term administration (7days) of Iso with Dob at a dose of 40μg/mouse/day in 12-week-old C57BL/6 female mice. Cardiac function was determined with transthoracic echo cardiography (ECHO) 24 hours after the last dose. Cardiac wet weights increased 33% and 24% in the Iso and Dob groups compared with controls (p < 0.05). Dob and Iso significantly increased cardiac fibrosis and decreased cardiac function with chronic administration. Administration also resulted in increased left atrial size, suggesting that both Dob and Iso decreased LV compliance, but did not induce heart failure. In conclusion, chronic administration of Dob may have a detrimental effect on cardiac structure and function.
ACCESSION #
36361572

 

Related Articles

  • Antituberculars/streptomycin.  // Reactions Weekly;10/27/2007, Issue 1175, p7 

    The article describes the case of a man who developed coronary thrombosis after the administration of aprotinin as antifibrinolytic therapy during repeat coronary bypass. The patient had a history of myocardial infarction and coronary bypass. Atrioventricular sequential pacing was required for a...

  • Drug May Help Stabilize Heart Failure Patients Without Side Effects of Traditional Therapies.  // Ascribe Newswire: Medicine;3/21/2001, p11 

    A new drug may stabilize patients with failing hearts quickly, without the side effects of traditional therapies. The drug, called tezosentan, helps increase the amount of blood pumped by the heart in acute heart failure patients, according to a Baylor College of Medicine study. Acute heart...

  • Protamine sulfate.  // Reactions Weekly;1/25/2014, Issue 1485, p31 

    The article presents a case study of a 6-day old infant who developed severe shock after treating with protamine sulfate following surgery under cardiopulmonary bypass.

  • Cardiovascular drugs: Linked to many errors. Santell, John P. // Drug Topics;6/20/2005, Vol. 149 Issue 12, DRUG TOPIC FOR THE HEALTH-SYSTEM p 

    This article reviews the safety of cardiovascular drugs. Drug products used to treat cardiovascular diseases like hypertension, congestive heart failure, and ischemia, have been associated with a significant number of adverse drug events. Cardiovascular drug products are among the most widely...

  • Effect of Hypocalcemia on Isoproterenol Induced Cardiotoxicity in Dogs. Darsinos, John Th.; Karh, Joan N.; Stathaki, Stamatina N.; Ziroyannis, Panayotis N.; Pistevos, Anastasios C.; Levis, Gabriel M.; Moulopoulos, Spyridon D. // Angiology;Mar1984, Vol. 35 Issue 3, p152 

    The effect of serum calcium on the myocardial damages produced by isoproterenol was studied in the dog. Hemodialysis for 80 min in the absence of calcium was used to alter serum calcium concentration in seven experimental animals. The same number of animals were dialysed in the presence of...

  • Isoprenaline.  // Reactions Weekly;2/20/2010, Issue 1289, p25 

    The article describes the case of a 13-year-old girl with atrial fibrillation who developed ventricular tachycardia while receiving isoprenaline.

  • Clopidogrel: The Good, the Bad, and the Ugly. Chow, Grant; Ziegelstein, Roy C. // American Journal of Cardiovascular Drugs;2007, Vol. 7 Issue 3, p169 

    The article comments on a paper which shows the clinical efficacy of clopidogrel in patients with acute coronary syndromes. They stress that the drug should be a target of disease management programs. They mention the side effects of the drug. He emphasizes the difficulty to argue with the...

  • High-Dose Statin Therapy, Value for Older Adults.  // Travel Medicine Advisor;Sep2007, Vol. 17 Issue 9, p1 

    The article focuses on the findings of a study on the potential significance of high-dose statin therapy in older people with stable coronary disease conducted in the U.S. Patients who received low-dose atorvastatin achieved average cholesterol levels of 100 mg/dl versus 70 mg/dl for high dose...

  • Early statin withdrawal can endanger patients with acute coronary syndrome.  // Drug Formulary Review;Mar2007, Vol. 23 Issue 3, p17 

    The article discusses research being done on the clinical implications of statin withdrawal. It references a study by L. X. Cubeddu published in the 2006 issue of "Pharmacotherapy." Researchers realize that the withdrawal of statin therapy will increase morbidity and mortality rates in patients...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics